We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Override of FDA Plan B Review Could Signal Precedent
HHS Override of FDA Plan B Review Could Signal Precedent
December 9, 2011
HHS Secretary Kathleen Sebelius’ decision to override a favorable review by CDER on OTC sales of Teva’s Plan B contraceptive could be a precedent-setting move that has put the FDA in uncomfortable political crosshairs amid its push to improve regulatory science and predictability.